Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

被引：0

作者：

Panagiotis Alexopoulos

Lukas Werle

Jennifer Roesler

Nathalie Thierjung

Lena Sophie Gleixner

Igor Yakushev

Nikolaos Laskaris

Stefan Wagenpfeil

Philippos Gourzis

Alexander Kurz

Robert Perneczky

机构：

[1] University Hospital of Rion,Department of Psychiatry

[2] University of Patras,Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar

[3] Technische Universität München,Department of Nuclear Medicine, Klinikum rechts der Isar

[4] Max Planck Institute of Psychiatry,Department of Informatics

[5] Technische Universität München,Institute of Medical Biometrics, Epidemiology, and Medical Informatics (IMBEI)

[6] Aristotle University of Thessaloniki,Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine

[7] University of the Saarland,Department of Psychiatry and Psychotherapy

[8] The Imperial College of Science,Department of Psychiatry

[9] Technology and Medicine,undefined

[10] Ludwig-Maximilans-Universität München,undefined

[11] University Hospital of Patras,undefined

[12] University of Patras,undefined

来源：

Alzheimer's Research & Therapy | / 8卷

关键词：

Prognosis; Alzheimer’s disease; Mild cognitive impairment; Cerebrospinal fluid;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 309 条

[1] McKhann GM(2011)The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement. 7 263-9
[2] Knopman DS(2011)Changing concepts of Alzheimer disease JAMA. 305 2458-9
[3] Chertkow H(2012)Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort Neurology. 78 47-54
[4] Hyman BT(2009)Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects Ann Neurol. 65 403-13
[5] Jack CR(2014)Who needs cerebrospinal biomarkers? A national survey in clinical practice J Alzheimers Dis. 40 857-61
[6] Kawas CH(2010)Diagnostic impact of CSF biomarkers in a local hospital memory clinic Dement Geriatr Cogn Disord. 29 491-7
[7] McKhann GM(2014)Impact of cerebro-spinal fluid biomarkers of Alzheimer’s disease in clinical practice: a multicentric study J Neurol. 261 144-51
[8] Schoonenboom NSM(2015)Diagnostic impact of CSF biomarkers for Alzheimer’s disease in a tertiary memory clinic Alzheimers Dement. 11 523-32
[9] Reesink FE(2013)Mild cognitive impairment due to Alzheimer disease in the community Ann Neurol. 74 199-208
[10] Verwey NA(2006)Do all patients with mild cognitive impairment progress to dementia? J Am Geriatr Soc. 54 1008-10